Overview
- WHO declared Mpox a global health emergency citing rising cases and deaths, particularly in children.
- Critics argue the disease's impact is minimal compared to other health crises like malaria and HIV in affected regions.
- Advocates emphasize the need for equitable access to vaccines and information, particularly for marginalized communities.
- Concerns raised about potential conflicts of interest and the financial gains for pharmaceutical companies.
- Calls for transparency and a balanced approach in addressing both Mpox and broader public health priorities.